Second FDA approval for BeiGene’s Tevimbra in 2024
Dec 27, 2024 · The US Food and Drug Administration (FDA) has approved Tevimbra (tislelizumab-jsgr), in combination with platinum and fluoropyrimidine-based chemotherapy, for …
Pharma, Biotech and Generics Industry News | The Pharmaletter
Jan 2, 2025 · In some good news for the US vaccines developer, whose stock has fallen 66% in the past 12 months, Moderna on Friday announced ongoing support from the US Department …
US FDA warning over counterfeit drugs bought in Mexico
May 15, 2005 · The US Food and Drug Administration is warning the public about the sale of counterfeit versions of Pfizer's Lipitor (atorvastatin) and Viagra (sildenafil), and an unapproved …
Eisai announces launch of Rozebalamin and Tasfygo
Nov 21, 2024 · Japanese drugmaker Eisai (TYO: 4523)has announced that the amyotrophic lateral sclerosis (ALS) treatment Rozebalamin for Injection (mecobalamin) has been launched …
Sanofi edging closer with rilzabrutinib in ITP | The Pharmaletter
Nov 6, 2024 · French drugmaker Sanofi (Euronext: SAN) has revealed the results from the Phase III LUNA 3 trial of rilzabrutinib, an oral bruton tyrosine kinase (BTK) inhibitor, in persistent or …
Pharma USA 2025 - The Pharmaletter
The two day event offers a variety of means for networking and collaboration: Hackathons offering a hyper-interactive session where attendees work as a team to hack strategic issues.
Viatris faces FDA import restrictions at Indian facility
Dec 24, 2024 · Viatris faces US FDA regulatory action on its Indore, India facility, with a warning letter and import alert restricting 11 products while exempting four for shortages. The company …
Sandoz Page - The Pharmaletter
Dec 17, 2024 · sandoz news page. The US Food and Drug Administration approved sotorasib (trade name Lumakras) with panitumumab Vectibix), from US biotech major Amgen, for adult …
Citryll raises 85 million euros | The Pharmaletter
Dec 9, 2024 · Dutch biotech Citryll, which is focused on treating immune-mediated inflammatory diseases by targeting neutrophil extracellular traps (NETs), today announced the successful …
Pharmaceutical Industry News | The Pharmaletter
Jan 9, 2025 · Medicines Discovery Catapult (MDC), the UK government-backed life sciences service dedicated to driving productivity and impact in drug R&D, has strengthened its …